These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 13880315)

  • 1. Complications associated with lysergic acid diethylamide (LSD-25).
    COHEN S; DITMAN KS
    JAMA; 1962 Jul; 181():161-2. PubMed ID: 13880315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental LSD poisoning and its relation to schizophrenia. Observations on 2 borderline cases of neurosis and schizophrenia treated by repeated administration of LSD].
    MANZINI B; SARAVAL A
    Riv Sper Freniatr Med Leg Alien Ment; 1960 Sep; 84():589-618. PubMed ID: 13766357
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysergic acid diethylamide: side effects and complications.
    COHEN S
    J Nerv Ment Dis; 1960 Jan; 130():30-40. PubMed ID: 13811003
    [No Abstract]   [Full Text] [Related]  

  • 4. [The action of mescaline and lysergic acid diethylamide (LSD-25) on the behavior of the guinea pig].
    Sivadjian J
    C R Acad Hebd Seances Acad Sci D; 1969 Feb; 268(6):984-5. PubMed ID: 4975588
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental action of lysergic acid diethylamide (LSD 25) on the leukocytes of the monkey Papio papio].
    Ruffié J; Colombies P; Grozdea J
    Bull Acad Natl Med; 1971 Mar 2-9; 155(9):180-9. PubMed ID: 4997650
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of certain vitamins and histamines on the LSD psychosis.
    BERTINO JR; KLEE GD; WEINTRAUB W
    J Ment Sci; 1959 Oct; 105():1095-9. PubMed ID: 13799992
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 8. Lysergic acid diethylamide causes photoreceptor cell damage through inducing inflammatory response and oxidative stress.
    Hu QD; Xu LL; Gong Y; Wu GH; Wang YW; Wu SJ; Zhang Z; Mao W; Zhou YS; Li QB; Yuan JS
    Cutan Ocul Toxicol; 2018 Sep; 37(3):233-239. PubMed ID: 29298533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-LYSERGIC ACID DIETHYLAMIDE (LSD): A REVIEW OF ITS PRESENT STATUS.
    HOFFER A
    Clin Pharmacol Ther; 1965; 6():183-255. PubMed ID: 14288188
    [No Abstract]   [Full Text] [Related]  

  • 10. THE FIGURAL AFTER-EFFECT AND LYSERGIC ACID DIETHYLAMIDE (LSD-25).
    KELM H; JENSEN SE; RAMSAY RW
    J Nerv Ment Dis; 1963 Dec; 137():557-60. PubMed ID: 14087675
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroretinogram.
    APTER JT; PFEIFFER CC
    Ann N Y Acad Sci; 1957 Mar; 66(3):508-13; discussion, 513-4. PubMed ID: 13425239
    [No Abstract]   [Full Text] [Related]  

  • 12. The analeptic action of lysergic acid diethylamide on reserpinesedated mice.
    BURTON RM
    Ann N Y Acad Sci; 1957 Mar; 66(3):695-7. PubMed ID: 13425252
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental analysis of the inhibitory action of lysergic acid diethylamide on cortical dendritic activity.
    PURPURA DP
    Ann N Y Acad Sci; 1957 Mar; 66(3):515-36. PubMed ID: 13425240
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysergic acid diethylamide causes mouse retinal damage by up-regulating p-JAK1/p-STAT1.
    Chen K; He X; Li C; Ou Y; Li Y; Lai J; Lv M; Li X; Ran P; Li Y
    Cutan Ocul Toxicol; 2020 Jun; 39(2):106-110. PubMed ID: 32064962
    [No Abstract]   [Full Text] [Related]  

  • 17. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSD toxicity: a suspected cause of death.
    Griggs EA; Ward M
    J Ky Med Assoc; 1977 Apr; 75(4):172-3. PubMed ID: 845494
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of intravenous administration of D-lysergic acid diethylamide on initiation of protein synthesis in a cell-free system derived from brain.
    Cosgrove JW; Brown IR
    J Neurochem; 1984 May; 42(5):1420-6. PubMed ID: 6707642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contradictions in LSD research.
    Jarvik LF
    Science; 1968 Nov; 162(3854):621. PubMed ID: 5682780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.